This is why retatrutide is new and different
Blue Cross Blue Shield took steps last year to curb those costs, announcing it would no longer automatically cover the drugs, known by brand names such as Wegovy or Zepbound, when prescribed solely for weight loss
Potential influences on treatment duration: Degree of initial excess weight Medical history and concurrent conditions Tolerance and side effects from the medication Lifestyle changes implemented alongside semaglutide Lastly, lifestyle interventions add value to semaglutide treatment
CrossRef A comparative study between ultrasound-guided-attenuation-parameter (UGAP), controlled attenuation parameter (CAP), and proton density fat fraction (PDFF) for assessment of hepatic steatosis Marie Byenfeldt, Christer Grnlund, Patrik Nasr, Anna Lindam, Mattias Ekstedt, Peter Lundberg, Johan Kihlberg Scandinavian Journal of Gastroenterology .2026